文献速递疼痛医学神经外科与老年麻醉

Agrin蛋白亚型对大鼠链脲佐菌素糖尿病神经病理性疼痛的影响

The Effects of Agrin Isoforms on Diabetic Neuropathic Pain in a Rat Streptozotocin Model.
PubMed 文献 · Anesth Analg · 2018-01-01

研究在大鼠链脲佐菌素模型中比较不同分子量Agrin蛋白鞘内注射对糖尿病神经病理性疼痛的作用。结果显示仅50 kDa Agrin在0.2和2 ng剂量下抑制疼痛行为,单次给药效应持续4小时,并增强脊髓GABA能抑制性突触电流。25和75 kDa Agrin无明显效应。

要点

  • 仅50 kDa Agrin鞘内注射抑制糖尿病神经病理性疼痛,25和75 kDa亚型无效。
  • Agr50单次给药后抑制效应持续4小时,提高机械缩足阈值。
  • Agr50增强脊髓GABA能自发抑制性突触后电流和GABA神经元动作电位发放。

核心结论

  • Agr50对糖尿病神经病理性疼痛有强效抑制作用,并增强脊髓GABA能抑制性突触电流和GABA神经元动作电位发放率。
  • Agr50可能成为糖尿病神经病理性疼痛的潜在治疗手段。

研究设计与样本

  • 大鼠腹腔注射55 mg/kg链脲佐菌素诱导糖尿病,对出现神经病理性疼痛的糖尿病大鼠鞘内注射不同剂量纯化Agrin蛋白。
  • 通过触觉异常性疼痛测试评估糖尿病神经病理性疼痛是否被抑制,并用脊髓切片膜片钳记录分析Agrin效应。

主要发现

  • Agr50在0.2和2 ng鞘内给药时抑制糖尿病神经病理性疼痛,而Agr25和Agr75效果甚微。
  • Agr50单次推注后抑制效应持续4小时。
  • Agr50组平均缩足阈值从治疗前4.6 ± 2.2 g升至治疗后26 ± 0 g;Agr25组从4.9 ± 2.0 g至4.9 ± 2.0 g;Agr75组从5.3 ± 2.3 g至9.2 ± 2.5 g,组间差异P < .01。
  • 脊髓切片上Agr50增加自发性GABA能电流活动,提示增加自发性抑制性突触后电流和GABA神经元动作电位发放率,而Agr25和Agr75无此效应。

临床怎么用

  • Agr50鞘内给药可能作为糖尿病神经病理性疼痛的潜在治疗方向。
  • Agr25和Agr75在此模型中未见明显镇痛作用,亚型选择对疗效至关重要。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes mellitus affects 9.3% of the US population and increases risks of surgery and complications. Diabetic neuropathic pain (DNP), one of the main consequences of diabetes mellitus, is extremely difficult to treat. Current medications yield limited benefits and/or have severe adverse effects. Therefore, new, effective treatment is needed. METHODS: Streptozotocin at 55 mg/kg was injected intraperitoneally in rats to induce diabetes mellitus. Diabetic rats exhibiting neuropathic pain underwent intrathecal injection of purified agrin proteins at various doses and were then tested for tactile allodynia to evaluate whether DNP was inhibited. The agrin effects were also analyzed with patch-clamp recording on spinal cord slices. RESULTS: Fifty-kilo Dalton agrin (Agr50) at 0.2 and 2 ng suppressed DNP when given intrathecally, while 25- and 75-kDa agrin (Agr25, Agr75) had little effect. The suppressive effect of Agr50 lasted 4 hours after a single bolus injection. The difference in effects of Agr50 on mean withdrawal threshold (4.6 ± 2.2 g before treatment to 26 ± 0 g after treatment) compared with that of Agr25 (4.9 ± 2.0 g to 4.9 ± 2.0 g) and Agr75 (5.3 ± 2.3 g to 9.2 ± 2.5 g) was highly significant (P < .01). On spinal cord slices, Agr50 increased spontaneous GABAergic current activities, suggesting increased spontaneous inhibitory postsynaptic currents and action potential firing rate from GABA neurons, whereas Agr25 and Agr75 had no such effect. CONCLUSIONS: Agr50 had a potent suppressive effect on DNP and increased spontaneous inhibitory postsynaptic currents and action potential firing rate from GABA neurons. Therefore, Agr50 may provide a potential therapy for DNP.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Erasso D, Tender GC, Li Q, et al. The Effects of Agrin Isoforms on Diabetic Neuropathic Pain in a Rat Streptozotocin Model. Anesth Analg. 2018. PMID: 29369095. doi:10.1213/ANE.0000000000002773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。